Zacks - Logo

This Investment Opportunity Could
Touch Every Single Person
on the Planet...

Cutting-Edge Medical Stocks May Hand You the Biggest Gains of Your Life

Fellow Investor,

We're on the brink of a technological revolution that has been called "the medical equivalent of splitting the atom."

Reports of tumors melting away in a matter of days... of inoperable cancer going into complete remission... death sentences being erased...

I'm talking about immuno-oncology.

It is a fundamental change in the way we think about cancer and cancer treatment – a shift that could one day make traditional treatments obsolete.

Surgery, radiation and chemotherapy either poison the body or cutting parts of it out in an attempt to fight the disease. Immunotherapy stimulates and super-charges the patient's own immune system to defeat the rogue cells.

Not only is this entirely new territory for medicine, but it's arguably the most exciting and profitable industry to invest in today.

I'm Kevin Cook, Senior Stock Strategist at Zacks Investment Research. I'm going to tell you a little more about the science AND the incredible opportunity it creates for investors in just a moment.

First, I'd like to share a real-life example of the power of immunotherapy.

The Amazing Case Study of a Patient Named Jason

After 4 years of intense treatment, Jason's doctor gave him the worst kind of bad news.

Four years of radiation and chemotherapy had failed him. Instead of improving his condition, his cancer got worse. He had developed a 15-pound tumor in his left lung. It was so big that it bulged out of his back.

Jason's body couldn't take it anymore...

All the doctor could do is make Jason's final days as comfortable as possible.

Surprise Prediction Accuracy Chart

As a last–ditch, nothing–to–lose effort, Jason agreed to try an experimental drug. This drug, called a checkpoint inhibitor, destroys cancer's ability to block normal immune response. It unleashes killer T–Cells to attack with full force.

The results were dramatic to say the least.

After just 3 days, his tumor had visibly shrunk, and within 6 weeks, the cancer was in full remission!

Think about that. A man went from his deathbed to cancer–free in less than 2 months! Without having to go under the knife or go through brutal rounds of radiation and chemo.

Scientists Are Finally Cracking Cancer's Secret Codes

Jason's story is just one of many remarkable success stories coming out of the world of immunotherapy.

Researchers are just scratching the surface of what's possible. Ultimately, their discoveries could save hundreds of thousands or even millions of lives.

For centuries, we've resorted to drastic, often dangerous ways treat cancer.

  • Surgery has been used to remove tumors since ancient Egypt!
  • Radiation and chemotherapy often cause severe fatigue, hair loss, lowered resistance to infections, even heart and lung conditions.
  • Both radiation and chemotherapy have been shown to cause "second cancers" different from the one they were used to treat.

Doctors have known that exposure to radiation and chemicals can actually cause cancer since the early 1900s. But they didn't have any other options to fight the disease.

Until now.

Immunotherapy is now possible because of major advances in our understanding of how cancer operates.

Zacks Rank Timeline

No chemotherapy drug works so well on so many patients...You've taken a disease that was destined to end somebody's life very quickly, and you've completely changed it"
Dr. Louis Weiner, Director of the Lombardi Comprehensive Cancer Center

Dr. Louis Weiner, Director of the Lombardi Comprehensive Cancer Center at Georgetown University puts it this way:

"Every so–called successful cancer has had to figure out a way to either evade or overpower the immune system in which it is growing... If you can understand the tools that the cancers are using to defeat their own body's immune system, you ought to be able to treat that cancer."

As scientists have started to understand the tools cancer cells use to hide themselves, they've begun developing their own tools to give the immune system the upper hand.

That's What Makes This Industry Doubly Exciting

Number 1, Immuno–oncology is turning many cancers from terminal diseases into treatable conditions.

According to recent statistics, as much as half of the planet's population could get cancer in their lifetime. Every step forward we take in the war against cancer will have enormous impact.

Number 2, the companies that develop these treatments could potentially hand you some of the biggest investment gains you've seen in your lifetime.

INCY Chart

For example, Incyte climbed +951% after bringing their anti–cancer drug Jakafi to the market in 2011.

That's enough to turn $10,000 into more than $95,000.

Opportunities like these can be life-changing for both patients AND investors.

Shaking Up the Multi–Trillion Dollar Healthcare Industry

Quantum leaps in the science behind immunotherapy and other medical developments is 1 of 4 unstoppable megatrends that are already revolutionizing healthcare industry, which is worth $4 trillion a year in the U.S. alone.

They're already creating massive profit opportunities, too.

I call Megatrend #1 Boomer Power. One in 8 people in the world are 60+ years old, and that percentage is increasing every year. The United Nations has said this is "one of the most significant trends of the 21 century."

The average life expectancy is also on the rise.

What does that mean? More seniors needing more medicines and more healthcare for a longer time.

Unstoppable Megatrend #2 is Science Power. Major advancements are taking place across the medical field.

You've seen how immunotherapy is revolutionizing cancer treatment. Millions of people could have years added to their lives.

And this is just ONE area where medical science is exploding. That leads us right into the next megatrend.

Unstoppable Megatrend #3 is Earnings Power. Breakthroughs that save lives and improve quality of life will create opportunity.

Smaller biotech companies are pouring billions of dollars into cutting-edge research and development. They wouldn't do that if they weren't going to profit.

Unstoppable Megatrend #4 is Mergers & Acquisitions Power. Big pharmaceutical companies are constantly on the prowl, looking to buy fresh science to keep innovative drugs in their pipelines.

When mergers and acquisitions happen, look out! There's been over $500 billion in Biopharma M&A since 2009. The next couple years could see just as much activity, if not more.

GILD Chart

Why is this so significant? One quick example is Gilead Sciences, which purchased a company called Pharmasset in 2013 to get their hands on its groundbreaking Hepatitis C drug Sovaldi.

Gilead's Sovaldi revenue shot through the roof - and its share price followed along, soaring +426% in the next 3 years.

This is just one example of how Big Pharma's insatiable appetite for new drugs can turn into tremendous gains for well-informed investors.

These Megatrends Are Literally Unstoppable...

Zacks - Healthcare Innovators - Logo

No matter what's going on in Washington, no legislation can slow down the aging population, the advances in medical science and the unbelievable wealth that they will create in the coming years.

And now Zacks is providing a way to take full advantage.

Introducing Healthcare Innovators, Zacks' newest portfolio service.

Today I invite you look inside Zacks' first portfolio service that focuses exclusively on healthcare stocks with extreme long-term growth potential.

We're tracking for stocks that have the greatest chances of capitalizing on the 4 megatrends we've talked about. This gives us exposure to:

  • State-of-the-art biotech companies
  • Drug makers producing life-saving new products
  • Medical devices that change the way patients receive treatment and enhance their quality of life
  • Leading hospitals and care facilities
  • Healthcare companies from across the spectrum that are prime targets for huge buyouts from larger companies.

Healthcare Innovators will typically hold 15-25 stocks with strong Zacks Rank profiles. We'll keep them in the portfolio as long as we see long-term profits to be made. Think more in terms of years than months.

Right now, I'm closely monitoring 3 companies producing the next wave of breakthrough immunotherapy drugs...

...what the National Cancer Institute has called a class of living drugs... the "fifth pillar of cancer treatment."

Their radical approach to cancer treatment will create unbelievable wealth in the coming years, and today, you can position yourself right in front of the money flow. I will soon reveal their names and it will cost you almost nothing to see these picks the moment I post them.

Normally, access to Healthcare Innovators will be closed to the public, but when available its cost will be $955 per year and a bargain at that.

How much does it cost right now? Only $1.

You can be first in line to see these three companies plus all my initial moves for the sum total of only $1.

And that tiny amount covers a lot more than the Healthcare Innovators investments. It admits you to our Zacks Ultimate program which reveals ALL the buys and sells from ALL Zacks portfolios for a full 30 days without any obligation whatsoever.

Or you can receive 12 months of alerts with buy/sell recommendations and detailed market commentary for just $995 by clicking here.

The Ultimate $1 Opportunity

Let's take a look at what you get with your $1 Zacks Ultimate trial:

  • Buys and Sells from all of Zacks' portfolios (including the Healthcare Innovators.)
  • One Month.
  • One Dollar.
  • Not One Cent of Further Obligation.

How much does it cost right now? Only $1.

You can be first in line to see these three companies plus all my initial moves for the sum total of only $1.

And that tiny amount covers a lot more than the Healthcare Innovators investments. It admits you to our Zacks Ultimate program which reveals ALL the buys and sells from ALL Zacks portfolios for a full 30 days without any obligation whatsoever.

Or you can receive 12 months of alerts with buy/sell recommendations and detailed market commentary for just $995 by clicking here.

The Ultimate $1 Opportunity

Let's take a look at what you get with your $1 Zacks Ultimate trial:

  • Buys and Sells from all of Zacks' portfolios (including the Healthcare Innovators.)
  • One Month.
  • One Dollar.
  • Not One Cent of Further Obligation.

What's the catch? There really isn't one. We offer this arrangement to you because Zacks Ultimate serves as a showroom where you can check out any or all of our high-performance portfolios. Then you may join the ones that suit you best. Or join none of them. The choice is up to you - Get on the waiting list now!

What's the catch? There really isn't one. We offer this arrangement to you because Zacks Ultimate serves as a showroom where you can check out any or all of our high-performance portfolios. Then you may join the ones that suit you best. Or join none of them. The choice is up to you.

What's the catch? There really isn't one. We offer this arrangement to you because Zacks Ultimate serves as a showroom where you can check out any or all of our high-performance portfolios. Then you may join the ones that suit you best. Or join none of them. The choice is up to you.

▸ More information about Zacks Ultimate.

Let me make a suggestion: Go ahead and explore the Healthcare Innovators plus our other active trading and long-term investing portfolios packed inside Zacks Ultimate. Below you will see a list of all the services available to you for the next 30 days.

You might sample our momentum and insider trading stocks. Or see the recommendations of Zacks.com chief Steve Reitmeister just before he puts his own money into them. No matter what kind of investor you are, there are timely buy and sell recommendations to help you make more money in the market.

Will this be hard work? Will it be too much information? Not at all. During the next 30 days you can focus on the Healthcare Innovators picks and commentary while browsing the others, test-driving whatever captures your interest.

And then, after your $1 for 1 month trial, you have three simple choices:

  • 1. Walk out of the showroom anytime you please and not pay one cent more.
  • 2. Continue your see-it-all Zacks Ultimate subscription for only $299 a month.
  • 3. Join just one or more of the individual portfolios.

Once again, the choice is entirely up to you.

Backed by 2 Airtight Guarantees

Satisfaction Guarantee Shield

Don't worry, you are covered by a Satisfaction Guarantee. You may cancel up to 90 days after your trial is over. And if you feel we have not exceeded your expectations, then we will refund every last cent - including the $1 you paid for the trial. No problem.

But that isn't the half of it.

Perfomance Guarantee Shield

You're also backed by a full-year, money-back Performance Guarantee. Details. That means if we don't help you beat the market, we don't deserve your money.

No one else offers a combination of money-back assurances like these. That's because no one else has a proven system like the Zacks Rank that beats the market so consistently, year after year.

Healthcare Innovators is closed to new investors Important: Deadline to enter Healthcare Innovators is Sunday, April 23 1-Day Extension: Healthcare Innovators is open to new investors until April 24

To maximize the benefits of this service, we must limit the number of members who have access to its buys and sells. The portfolio is closed to new investors. Get on the waiting list to be notified of the next opening.

To maximize the benefits of this service, we must limit the number of members who have access to its buys and sells. The portfolio closes to new investors midnight Sunday, April 23.

But it may have to close even sooner if demand becomes too great.

Don't miss this brief window of opportunity to jump aboard companies at the forefront of the healthcare revolution, and also to sample all of Zacks' other services at so little cost and at no further obligation. It could be the best dollar you ever invested!

Call toll-free 1.888.775.8348 M-F, 10 am - 6 pm ET. Outside the U.S., 1.312.265.9309.

Simpler still, click here to get started online right now.

I'll soon reveal 3 companies that are producing the next wave of immunotherapy drugs. Their research could save countless lives and create billions of dollars in revenue.

I look forward to sharing these special companies with you during the next 30 days, and for many years to come.

To maximize the benefits of this service, we must limit the number of members who have access to its buys and sells. The portfolio closes to new investors midnight Monday, April 24.

Don't miss this brief window of opportunity to jump aboard companies at the forefront of the healthcare revolution, and also to sample all of Zacks' other services at so little cost and at no further obligation. It could be the best dollar you ever invested!

Call toll-free 1.888.775.8348 M-F, 10 am - 6 pm ET. Outside the U.S., 1.312.265.9309.

Simpler still, click here to get started online right now.

I'll soon reveal 3 companies that are producing the next wave of immunotherapy drugs. Their research could save countless lives and create billions of dollars in revenue.

I look forward to sharing these special companies with you during the next 30 days, and for many years to come.

Sincerely,

Zacks - Strategist - Kevin Cook
Kevin Cook,
Senior Stock Strategist

This portfolio is currently closed to new investors. Get on the waiting list. Closing to Public Entry in Get In Now » Deadline Extended: Closing in Get In Now »